# AcuityMD

> AcuityMD is a Boston-based commercial intelligence platform built specifically for the medical device (MedTech) industry. It translates large volumes of healthcare claims and procedure data into intuitive workflows, AI-powered insights, and recommendations that help medical device sales and marketing teams find high-value physicians and care sites, size and segment markets, manage territories, and accelerate product adoption. Founded in 2019 by former MedTech and consulting operators, the company serves hundreds of device makers - including a majority of the largest MedTech firms - and raised an $80M Series C in 2026 at a near-$1B valuation.

- **Founded:** 2019
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Michael Monovoukas (CEO & Co-founder), Robert Coe (CTO & Co-founder), Lee Smith (Co-founder, Head of Commercial Development)
- **Team size:** ~220 employees
- **Products:** Targeting, Markets, Territories, Pipeline, Care Journeys
- **Notable:** Raised $80M Series C in April 2026 at a near-$1B ($955M) valuation, bringing total funding to more than $160M, Serves 16 of the top 20 MedTech companies, Reported over $4B in sales pipeline surfaced through the platform

## Products & services

- **Targeting** — Identifies high-value healthcare providers and care sites using procedure volumes and historical product usage so reps know who to call next.
- **Markets** — Defines, sizes, and segments target markets using procedure and diagnosis codes plus geographic filters.
- **Territories** — Optimizes sales coverage and resource allocation with region-specific data for balanced, data-driven territory design.
- **Pipeline** — Automates sales-cycle management, opportunity tracking, and forecasting, replacing manual CRM logging.
- **Care Journeys** — Traces patient pathways and physician referral networks to reveal upstream referrers and downstream adoption opportunities.
- **Contracts** — Contract intelligence and compliance tooling for managing device agreements across accounts.
- **AcuityAI** — Agentic, AI-powered insights layer that surfaces recommendations, drafts next steps, and answers commercial questions across the platform.

## Achievements

- Raised $80M Series C in April 2026 at a near-$1B ($955M) valuation, bringing total funding to more than $160M
- Serves 16 of the top 20 MedTech companies
- Reported over $4B in sales pipeline surfaced through the platform
- Reported ~317% ARR growth and triple-digit customer growth in early scaling years
- Backed by Benchmark, Redpoint, ICONIQ, StepStone, and Atreides Management

## Latest updates

- **2026-04** — Raised $80M Series C led by StepStone Group to fund agentic AI development and strengthen its underlying MedTech data model; valuation neared $1B.
- **2025** — Expanded AcuityAI, its agentic AI insights layer, across the platform.
- **2024-06** — Closed a $45M Series B to expand the commercial intelligence platform to more medical technology manufacturers.

## Links

- Website: https://acuitymd.com
- LinkedIn: https://www.linkedin.com/company/acuitymd
- Twitter/X: https://twitter.com/acuitymd

---

Profile page: https://yespress.io/acuitymd
Published by YesPress — https://yespress.io
Last updated: 2026-07-22